PulseAugur
LIVE 10:22:55
tool · [1 source] · · 中文(ZH) 泰恩康:子公司和胃整肠丸获得药品注册证书
6
tool

Taien Kang subsidiary receives drug registration for Hewei Zhengchang Pill

Taien Kang's subsidiary, Anhui Taien Kang Pharmaceutical Co., Ltd., has received a Drug Registration Certificate from China's National Medical Products Administration for its "Hewei Zhengchang Pill." This traditional Chinese medicine is classified as a Category 4 drug and is intended to warm the stomach, regulate qi, and relieve pain, addressing symptoms like abdominal pain and diarrhea. The company acknowledges that future sales performance is subject to market and policy uncertainties. AI

Summary written by gemini-2.5-flash-lite from 1 source. How we write summaries →

RANK_REASON This is a product registration for a specific drug by a subsidiary of a company, not a major industry-wide release or significant event.

Read on 36氪 (36Kr) →

COVERAGE [1]

  1. 36氪 (36Kr) TIER_1 中文(ZH) ·

    Tainkang: Subsidiary's Stomach and Intestine Pill Receives Drug Registration Certificate

    36氪获悉,泰恩康公告,公司全资子公司安徽泰恩康制药有限公司于近日收到国家药品监督管理局签发的和胃整肠丸《药品注册证书》。该药品为中药4类(同名同方药),主要作用为温中和胃、理气止痛,能够迅速调理肠胃,缓解腹痛腹泻症状。该产品未来的具体销售情况可能受到行业政策、市场环境等因素影响,具有不确定性。